Andrew Round

Dr, Andrew Round is Investment Director at Deepbridge. Prior to joining Deepbridge, Andy has been an investor in Healthcare and Life Science companies for the past 15 years with Praetura Ventures, Maven Capital Partners and now Deepbridge. Andy has several Healthcare exits under his belt and has managed investments from both EIS and VCT funds as well as public/private funds and balance sheet investments. Andy has also worked as a consultant for companies such as DSM, Sumitomo Chemical, Bayer and Lanxess advising them and assisting them on Mergers and Acquisitions. Andy has also been a Founder in an early-stage Biotech company that raised in excess of £60m and was listed on AiM, using microbes as a drug delivery vehicle.